|
1- [(11Z,14Z)- icosadienoyl]- 2- [(4Z,7Z,10Z,13Z,16Z)- docosapentaenoyl]- sn- glycero- 3- phosphoethanolamine |
|
CHEBI:131662 |
|
1-[(11Z,14Z)-icosadienoyl]-2-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphoethanolamine |
|
A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at positions 1 and 2 are specified as (11Z,14Z)-icosadienoyl and (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl respectively. |
|
![](images/goldenstar.gif) ![](images/goldenstar.gif)
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C47H80NO8P/c1- 3- 5- 7- 9- 11- 13- 15- 17- 19- 21- 22- 24- 26- 28- 30- 32- 34- 36- 38- 40- 47(50) 56- 45(44- 55- 57(51,52) 54- 42- 41- 48) 43- 53- 46(49) 39- 37- 35- 33- 31- 29- 27- 25- 23- 20- 18- 16- 14- 12- 10- 8- 6- 4- 2/h11- 14,17- 20,22,24,28,30,34,36,45H,3- 10,15- 16,21,23,25- 27,29,31- 33,35,37- 44,48H2,1- 2H3,(H,51,52) /b13- 11- ,14- 12- ,19- 17- ,20- 18- ,24- 22- ,30- 28- ,36- 34- /t45- /m1/s1 |
YKGWPFOSRMGOGZ-BDJNJYPGSA-N |
C(OP(=O)(OCCN)O)[C@@H](COC(CCCCCCCCC/C=C\C/C=C\CCCCC)=O)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
|
|
View more via ChEBI Ontology
Outgoing
|
1- [(11Z,14Z)- icosadienoyl]- 2- [(4Z,7Z,10Z,13Z,16Z)- docosapentaenoyl]- sn- glycero- 3- phosphoethanolamine
(CHEBI:131662)
has functional parent
(11Z,14Z)-icosadienoic acid
(CHEBI:73731)
1- [(11Z,14Z)- icosadienoyl]- 2- [(4Z,7Z,10Z,13Z,16Z)- docosapentaenoyl]- sn- glycero- 3- phosphoethanolamine
(CHEBI:131662)
has functional parent
(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid
(CHEBI:65136)
1- [(11Z,14Z)- icosadienoyl]- 2- [(4Z,7Z,10Z,13Z,16Z)- docosapentaenoyl]- sn- glycero- 3- phosphoethanolamine
(CHEBI:131662)
has role
mouse metabolite
(CHEBI:75771)
1- [(11Z,14Z)- icosadienoyl]- 2- [(4Z,7Z,10Z,13Z,16Z)- docosapentaenoyl]- sn- glycero- 3- phosphoethanolamine
(CHEBI:131662)
is a
1,2-diacyl-sn-glycero-3-phosphoethanolamine
(CHEBI:64674)
|
|
(6Z,9Z,23R)- 29- amino- 26- hydroxy- 20,26- dioxo- 21,25,27- trioxa- 26λ5- phosphanonacosa- 6,9- dien- 23- yl (4Z,7Z,10Z,13Z,16Z)- docosa- 4,7,10,13,16- pentaenoate
|
1-Eicosadienoyl-2-docosapentaenoyl-sn-glycero-3-phosphoethanolamine
|
HMDB
|
GPEtn(20:2/22:5)
|
HMDB
|
GPEtn(20:2n6/22:5n6)
|
HMDB
|
GPEtn(20:2w6/22:5w6)
|
HMDB
|
GPEtn(42:7)
|
HMDB
|
PE(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
|
ChEBI
|
PE(20:2/22:5)
|
HMDB
|
PE(20:2n6/22:5n6)
|
HMDB
|
PE(20:2w6/22:5w6)
|
HMDB
|
PE(42:7)
|
HMDB
|
Phosphatidylethanolamine(20:2/22:5)
|
HMDB
|
Phosphatidylethanolamine(20:2n6/22:5n6)
|
HMDB
|
Phosphatidylethanolamine(20:2w6/22:5w6)
|
HMDB
|
Phosphatidylethanolamine(42:7)
|
HMDB
|
27471436
|
PubMed citation
|
Europe PMC
|
|